文献速递脑血管病

完全血管造影再灌注前的静脉溶栓:超越血管造影评估以靶向微血管阻塞?

Intravenous Thrombolysis before Complete Angiographic Reperfusion: Beyond Angiographic Assessment to Target Microvascular Obstruction?
PubMed 文献 · Ann Neurol · 2024-01-10

在法国21个中心的前瞻性观察性ETIS注册研究中,纳入2015年1月至2021年12月间前循环大血管闭塞、EVT后完全再灌注且发病6小时内的患者,比较EVT前使用IVT与未使用IVT的临床与安全结局。倾向评分匹配后,IVT+EVT组90天mRS分布有利偏移(aOR=1.41,95%CI=1.04-1.91,p=0.023),良好结局率更高(61.1% vs 48.7%,aOR=1.49,95%CI=1.02-2.20,p=0.041),症状性颅内出血率两组相当(6.0% vs 4.3%,aOR=1.16,95%CI=0.53-2.54,p=0.709)。

要点

  • EVT后完全血管造影再灌注患者中,EVT前IVT与90天mRS分布有利偏移相关(aOR=1.41)。
  • IVT+EVT组90天良好结局率61.1%,EVT单独组48.7%,aOR=1.49。
  • 两组症状性颅内出血率相当(6.0% vs 4.3%),未增加出血风险。

核心结论

  • 在临床实践中,即使EVT达到完全血管造影再灌注,EVT前使用IVT仍改善患者临床结局且不增加出血风险。

研究设计与样本

  • ETIS注册研究为在法国21个中心开展的前瞻性观察性研究。
  • 纳入2015年1月至2021年12月间颅内颈内动脉或大脑中动脉(M1/M2段)前循环大血管闭塞、EVT后完全再灌注(eTICI评分=3)且发病6小时内患者。
  • 共5429例患者纳入ETIS注册,1093例纳入本研究,其中651例EVT前接受IVT。
  • 倾向评分匹配后,488例EVT前接受IVT患者与337例未接受IVT患者进行比较。

主要发现

  • 匹配队列中,IVT+EVT组90天mRS评分分布有利偏移(aOR=1.41,95%CI=1.04-1.91,p=0.023)。
  • IVT+EVT组90天良好结局(mRS 0-2)率61.1%,EVT单独组48.7%(aOR=1.49,95%CI=1.02-2.20,p=0.041)。
  • 两组症状性颅内出血率相当(IVT+EVT组6.0% vs EVT单独组4.3%,aOR=1.16,95%CI=0.53-2.54,p=0.709)。

关键数值与推荐

  • 完全再灌注定义为expanded Thrombolysis in Cerebral Infarction(eTICI)评分=3。
  • 主要结局为90天改良Rankin量表(mRS)残疾程度分布偏移。
  • 次要结局包括90天良好结局(mRS 0-2)。
  • 安全性结局包括症状性颅内出血和90天死亡率。
  • 多因素logistic模型校正年龄、美国国立卫生研究院卒中量表评分、Alberta卒中项目早期CT评分及症状发作至穿刺时间。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent data have suggested that ineffective tissue reperfusion despite successful angiographic reperfusion was partly responsible for unfavorable outcomes after endovascular therapy (EVT) and might be modulated by intravenous thrombolysis (IVT) use before EVT. To specifically decipher the effect played by IVT before EVT, we compared the clinical and safety outcomes of patients who experienced a complete reperfusion at the end of EVT according to IVT use before EVT. METHODS: The Endovascular Treatment in Ischemic Stroke (ETIS) registry is an ongoing, prospective, observational study at 21 centers that perform EVT in France. Patients were included if they had an anterior large vessel occlusion of the intracranial internal carotid artery or middle cerebral artery (M1/M2 segments) and complete reperfusion (expanded Thrombolysis in Cerebral Infarction score = 3) with EVT within 6 hours, between January 2015 and December 2021. The cohort was divided into two groups according to IVT use before EVT, and propensity score matching (PSM) was used to balance the two groups. Primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale (mRS) at 90 days. Secondary outcomes included favorable outcome (mRS 0-2) at 90 days. Safety outcomes included symptomatic intracranial hemorrhage and 90-day mortality. Outcomes were estimated with multivariate logistic models adjusted for age, National Institutes of Health Stroke Scale, Alberta Stroke Program Early CT Score, and time from symptom onset to puncture. RESULTS: Among 5,429 patients included in the ETIS registry, 1,093 were included in the study, including 651 patients with complete recanalization treated with IVT before EVT. After PSM, 488 patients treated with IVT before EVT were compared to 337 patients without IVT. In the matched cohort analysis, the IVT+EVT group had a favorable shift in the overall mRS score distribution (adjusted odds ratio [aOR] = 1.41, 95% confidence interval [CI] = 1.04-1.91, p = 0.023) and higher rates of favorable outcome (61.1% vs 48.7%, aOR = 1.49, 95% CI = 1.02-2.20, p = 0.041) at 90 days compared with the EVT alone group. Rates of symptomatic intracerebral hemorrhage were comparable between both groups (6.0% vs 4.3%, aOR = 1.16, 95% CI = 0.53-2.54, p = 0.709). INTERPRETATION: In clinical practice, even after complete angiographic reperfusion by EVT, prior IVT use improves clinical outcomes of patients without increasing bleeding risk. ANN NEUROL 2024;95:762-773.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Gory B, Finitsis S, Olivot JM, et al. Intravenous Thrombolysis before Complete Angiographic Reperfusion: Beyond Angiographic Assessment to Target Microvascular Obstruction? Ann Neurol. 2024. PMID: 38148607. doi:10.1002/ana.26867

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。